ArticleJournal for immunotherapy of cancer2021

Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages.

Da-Liang Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.